RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,372 | -22.9% | 33,837 | -13.3% | 0.00% | 0.0% |
| Q2 2023 | $729,637 | +4.0% | 39,018 | +2.0% | 0.00% | 0.0% |
| Q1 2023 | $701,833 | +5.9% | 38,247 | +14.2% | 0.00% | 0.0% |
| Q4 2022 | $662,884 | +43.2% | 33,479 | +73.5% | 0.00% | 0.0% |
| Q3 2022 | $463,000 | +77.4% | 19,299 | +34.5% | 0.00% | – |
| Q2 2022 | $261,000 | -6.8% | 14,348 | +12.7% | 0.00% | – |
| Q1 2022 | $280,000 | -35.8% | 12,736 | +7.3% | 0.00% | – |
| Q4 2021 | $436,000 | +22.1% | 11,870 | +3.4% | 0.00% | – |
| Q3 2021 | $357,000 | +20.2% | 11,481 | +22.6% | 0.00% | – |
| Q2 2021 | $297,000 | +28.6% | 9,367 | -10.4% | 0.00% | – |
| Q1 2021 | $231,000 | +12.7% | 10,457 | +0.6% | 0.00% | – |
| Q4 2020 | $205,000 | – | 10,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |